Two Sigma Investments
TENX icon

Two Sigma Investments’s Tenax Therapeutics TENX Stock Holding History

Two Sigma Investments’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.1M Buy
68,588
+35,118
+105% +$475K ﹤0.01% 3194
2025
Q4 		$408K Buy
+33,470
New +$291K ﹤0.01% 3427
2025
Q1 		– Sell
-13,521
Closed -$83.7K – 3481
2024
Q4 		$83.7K Buy
+13,521
New +$65.6K ﹤0.01% 2990
2024
Q1 		– Sell
-1,780
Closed -$39.1K – 3386
2023
Q4 		$39.1K Buy
+1,780
New +$42.7K ﹤0.01% 3015
2021
Q1 		– Sell
-25
Closed -$73K – 4240
2020
Q4 		$73K Sell
25
-55
-69% -$101K ﹤0.01% 3229
2020
Q3 		$196K Sell
80
-17
-18% -$36.3K ﹤0.01% 2829
2020
Q2 		$140K Buy
+97
New +$143K ﹤0.01% 2733

Other funds holding TENX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Two Sigma Investments's TENX Position: Q1 2026 in Review

Two Sigma Investments increased its Tenax Therapeutics (TENX) stake by 105% in Q1 2026, buying an estimated $475K and bringing the position to 68,588 shares worth $1.1M. The position accounts for ﹤0.01% of the portfolio, ranked #3194.

Two Sigma Investments first reported a position in TENX in Q2 2020 and has held it in 7 quarters since. 80 funds tracked by Wall St. Rank hold TENX as of Q1 2026.

  • Two Sigma Investments held 68,588 shares of Tenax Therapeutics worth $1.1M as of Q1 2026.
  • Two Sigma Investments bought 35,118 Tenax Therapeutics shares in Q1 2026, an estimated $475K.
  • Tenax Therapeutics made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #3194 holding.
  • Two Sigma Investments first reported a position in Tenax Therapeutics in Q2 2020 and has held it in 7 quarters since.
  • 80 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.